Platelet-to-Lymphocyte Ratio Is Associated With Favorable Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: A Study on 120 Patients

INTRODUCTION: Triple negative breast cancer (TNBC) is highly heterogeneous, but still most of the patients are treated by the anthracycline/taxane-based neoadjuvant therapy (NACT). Tumor-infiltrating lymphocytes (TILs) are a strong predictive and prognostic biomarker in TNBC, however are not always...

Descripción completa

Detalles Bibliográficos
Autores principales: Lusho, Sejdi, Durando, Xavier, Mouret-Reynier, Marie-Ange, Kossai, Myriam, Lacrampe, Nathalie, Molnar, Ioana, Penault-Llorca, Frederique, Radosevic-Robin, Nina, Abrial, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8331686/
https://www.ncbi.nlm.nih.gov/pubmed/34367964
http://dx.doi.org/10.3389/fonc.2021.678315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8331686/
https://www.ncbi.nlm.nih.gov/pubmed/34367964
http://dx.doi.org/10.3389/fonc.2021.678315

Ejemplares similares